{
  "nctId": "NCT04149405",
  "briefTitle": "Alterations of GCF Levels of Sclerostin and DKK-1 in Postmenopausal Osteoporosis",
  "officialTitle": "Investigation of the Effects of Bisphosphonate on the Gingival Crevicular Fluid Levels of Sclerostin and the DKK-1 in Individuals With Postmenopausal Osteoporosis With Periodontal Changes",
  "protocolDocument": {
    "nctId": "NCT04149405",
    "filename": "Prot_SAP_003.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2018-12-28",
    "uploadDate": "2020-09-11T13:16",
    "size": 69843,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT04149405/document/Prot_SAP_003.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "PHASE4"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "NON_RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "SINGLE",
  "enrollmentInfo": {
    "enrollmentCount": 43,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2016-06-30",
    "completionDate": "2018-12-28",
    "primaryCompletionDate": "2017-12-06",
    "firstSubmitDate": "2019-10-12",
    "firstPostDate": "2019-11-04"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Women with T scores less than -2.5 (groups A and C)\n* The periodontitis patients were selected based on the radiographical evidence of bone loss, presence of four or more sites with bleeding on probing (BOP), ≥5 mm pocket depth (PD) and ≥6 mm clinical attachment loss (CAL).\n* The clinically healthy control groups were selected on the basis of no radiographic bone loss or CAL and PD≤3 mm.\n\nExclusion Criteria:\n\n* Any known systemic disease rather than osteoporosis\n* Smoking\n* Antibiotic therapy within the last 3 months\n* Periodontal treatment in the last 6 months",
    "healthyVolunteers": true,
    "sex": "FEMALE",
    "minimumAge": "51 Years",
    "maximumAge": "66 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Sost Values for 6th Month",
        "description": "levels of sclerostin in 6th month",
        "timeFrame": "6 months"
      },
      {
        "measure": "Dkk-1 Values for 6th Month",
        "description": "levels of dickkopf-related protein-1 in 6th month",
        "timeFrame": "6 months"
      }
    ],
    "secondary": [
      {
        "measure": "Sost Values for 12th Month",
        "description": "levels of sclerostin in 12th month",
        "timeFrame": "12 month"
      },
      {
        "measure": "Dkk-1 Values for 12th Month",
        "description": "levels of dickkopf-related protein-1 in 12th month",
        "timeFrame": "12 months"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 2,
      "secondaryCount": 2,
      "otherCount": 0,
      "totalCount": 4
    },
    "studyDesign": {
      "phases": [
        "PHASE4"
      ],
      "isRandomized": false,
      "isMasked": true,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 49,
    "complexityCategory": "Moderate"
  },
  "collectionDate": "2025-09-22T02:30:04.222Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}